FGFR1OP expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.001200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.545400E-01
Normal-vs-Stage2
5.715600E-01
Normal-vs-Stage3
1.475590E-01
Normal-vs-Stage4
7.738200E-01
Stage1-vs-Stage2
7.472400E-01
Stage1-vs-Stage3
3.524200E-01
Stage1-vs-Stage4
7.504800E-01
Stage2-vs-Stage3
1.440220E-01
Stage2-vs-Stage4
2.151800E-01
Stage3-vs-Stage4
1.884600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.852800E-01
Normal-vs-AfricanAmerican
8.927600E-01
Normal-vs-Asian
7.813000E-01
Caucasian-vs-AfricanAmerican
3.533800E-01
Caucasian-vs-Asian
7.324400E-01
AfricanAmerican-vs-Asian
6.154600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.858600E-01
Normal-vs-Female
7.482000E-01
Male-vs-Female
2.356600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.925000E-01
Normal-vs-Age(41-60Yrs)
8.136200E-01
Normal-vs-Age(61-80Yrs)
4.827600E-01
Normal-vs-Age(81-100Yrs)
8.572400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.821400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.193200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.339000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.756100E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.421800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.299200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.640800E-01
Normal-vs-Daily Drinker
2.300800E-01
Normal-vs-Weekly Drinker
6.826400E-01
Normal-vs-Occasional Drinker
6.221000E-01
Normal-vs-Social Drinker
7.191800E-01
Non Drinker-vs-Daily Drinker
1.749360E-01
Non Drinker-vs-Weekly Drinker
9.924400E-01
Non Drinker-vs-Occasional Drinker
9.665000E-01
Non Drinker-vs-Social Drinker
6.856000E-01
Daily Drinker-vs-Weekly Drinker
2.470200E-01
Daily Drinker-vs-Occasional Drinker
2.098000E-01
Daily Drinker-vs-Social Drinker
6.881800E-02
Weekly Drinker-vs-Occasional Drinker
9.642400E-01
Weekly Drinker-vs-Social Drinker
7.198800E-01
Occasional Drinker-vs-Social Drinker
6.455000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.877400E-01
Normal-vs-Grade 2
5.883200E-01
Normal-vs-Grade 3
9.903500E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.387200E-01
Grade 1-vs-Grade 3
2.187200E-01
Grade 1-vs-Grade 4
2.877400E-01
Grade 2-vs-Grade 3
2.225800E-01
Grade 2-vs-Grade 4
5.883200E-01
Grade 3-vs-Grade 4
9.903500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.484200E-01
Normal-vs-NonDiabetic
6.259600E-01
Diabetic-vs-NonDiabetic
9.914100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.656800E-01
Normal-vs-NoPancreatitis
4.689000E-01
Pancreatitis-vs-NoPancreatitis
1.415410E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.878000E-01
Normal-vs-N1
5.549800E-01
N0-vs-N1
4.147400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.990600E-01
Normal-vs-TP53-NonMutant
7.717200E-01
TP53-Mutant-vs-TP53-NonMutant
3.029200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
